Treatment results of stroke patients aged >80 years receiving intravenous rt-PA.
Jauss
M
M
Department of Neurology, University of Giessen, Giessen, Germany. marek.jauss@kk-bottrop.de
Allendorfer
J
J
Stolz
E
E
Schutz
H-J
HJ
Misselwitz
B
B
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D019992:Databases as Topic; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D005858:Germany; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000008:administration & dosage; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator